Enovix (NASDAQ:ENVX) Issues Earnings Results

Enovix (NASDAQ:ENVX) issued its quarterly earnings data on Wednesday. The company reported ($0.14) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.15) by $0.01, FiscalAI reports. Enovix had a negative return on equity of 63.25% and a negative net margin of 499.64%.The business had revenue of $7.60 million during the quarter, compared to analysts’ expectations of $6.95 million. During the same period in the previous year, the firm posted ($0.15) earnings per share. The company’s revenue was up 49.1% on a year-over-year basis. Enovix updated its Q2 2026 guidance to -0.170–0.130 EPS.

Here are the key takeaways from Enovix’s conference call:

• Enovix said it has begun commercial production of its AI-1 smart eyewear battery, with initial shipments underway and production expected to ramp in the second half of 2026.
• The company reported progress on smartphone qualification, saying it and key OEMs have moved away from the legacy 0.7C test in favor of silicon-anode-specific protocols based on more realistic usage patterns.
• Enovix launched its MX1 drone battery at 360 Wh/kg and said demand from drones, defense, and industrial customers is growing, with a Korea pipeline now exceeding $130 million.
• Manufacturing execution at Fab 2 improved, with yields in most zones nearing or exceeding 90%, while Zone 1 dicing remains a bottleneck that the company plans to address with a hybrid laser/mechanical process.
• Q1 revenue came in at $7.6 million, up 49% year over year and above the top end of guidance, while the company ended the quarter with about $582.7 million in cash and marketable securities.

Enovix Trading Down 13.6%

NASDAQ:ENVX opened at $6.30 on Friday. The stock has a 50-day simple moving average of $5.80 and a 200-day simple moving average of $7.11. The stock has a market cap of $1.37 billion, a P/E ratio of -7.59 and a beta of 2.24. Enovix has a 1 year low of $4.61 and a 1 year high of $16.49. The company has a debt-to-equity ratio of 1.90, a quick ratio of 8.13 and a current ratio of 8.34.

Wall Street Analyst Weigh In

A number of brokerages have recently weighed in on ENVX. JPMorgan Chase & Co. cut Enovix from a “neutral” rating to an “underweight” rating in a research note on Wednesday, May 6th. Canaccord Genuity Group dropped their price objective on Enovix from $21.00 to $15.00 and set a “buy” rating for the company in a research note on Thursday, February 26th. Oppenheimer dropped their price objective on Enovix from $24.00 to $21.00 and set an “outperform” rating for the company in a research note on Thursday. Wells Fargo & Company set a $6.00 price objective on Enovix in a research note on Thursday, March 12th. Finally, B. Riley Financial dropped their price objective on Enovix from $17.00 to $10.00 and set a “buy” rating for the company in a research note on Monday, March 2nd. Seven investment analysts have rated the stock with a Buy rating, one has assigned a Hold rating and two have issued a Sell rating to the stock. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and an average price target of $12.64.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently made changes to their positions in the business. Invesco Ltd. lifted its holdings in shares of Enovix by 65.6% in the 4th quarter. Invesco Ltd. now owns 1,487,425 shares of the company’s stock valued at $10,873,000 after purchasing an additional 589,271 shares during the last quarter. Mackenzie Financial Corp purchased a new stake in shares of Enovix in the 4th quarter valued at about $77,000. NewEdge Advisors LLC lifted its holdings in shares of Enovix by 8.2% in the 4th quarter. NewEdge Advisors LLC now owns 39,607 shares of the company’s stock valued at $290,000 after purchasing an additional 3,012 shares during the last quarter. nVerses Capital LLC purchased a new stake in shares of Enovix in the 4th quarter valued at about $91,000. Finally, VARCOV Co. purchased a new stake in shares of Enovix in the 4th quarter valued at about $1,188,000. 50.92% of the stock is owned by institutional investors and hedge funds.

Key Enovix News

Here are the key news stories impacting Enovix this week:

• Positive Sentiment: Enovix reported Q1 2026 EPS of -$0.14, slightly ahead of estimates, and revenue of $7.6 million, also above expectations, with revenue up 49.1% year over year. The company also said it has begun commercial production of its silicon-anode smart eyewear battery and is progressing toward smartphone qualification completion. Article Title
• Positive Sentiment: Trading activity suggested elevated investor interest, with unusually large call option volume, which can reflect speculation that shares may rebound.
• Neutral Sentiment: Benchmark and Oppenheimer both kept positive ratings on ENVX while trimming targets to $15 and $21, respectively, suggesting analysts still see meaningful upside despite becoming more cautious. Article Title
• Neutral Sentiment: Craig Hallum and TD Cowen also lowered their targets to $8 and $7, reflecting more tempered expectations but not a full deterioration in long-term outlook. Article Title
• Negative Sentiment: The stock fell after the earnings report because investors focused on widening losses and management’s still-uncertain commercialization timeline, despite the beat on revenue and EPS. Article Title
• Negative Sentiment: Q2 guidance was softer on revenue and remained negative on EPS, reinforcing concerns that profitability is still distant. Article Title

About Enovix

Enovix Corporation (NASDAQ: ENVX) develops and manufactures advanced lithium-ion battery cells with a patented three-dimensional silicon-anode architecture. The company’s core focus is on delivering high energy density, improved safety, and longer cycle life compared to conventional graphite-based cells. Enovix’s technology targets a range of applications, including consumer electronics, wearable devices, electric vehicles and stationary energy storage systems.

Founded in 2011 and headquartered in Fremont, California, Enovix has built pilot production capability and is scaling up manufacturing capacity to meet growing demand.